Standard
Pneumonia risk : approximately one-third is due to clozapine and two-thirds is due to treatment-resistant schizophrenia. / Villasante-Tezanos, A. G.; Rohde, C.; Nielsen, J.; de Leon, J.
In:
Acta Psychiatrica Scandinavica, Vol. 142, No. 1, 2020, p. 66-67.
Research output: Contribution to journal › Comment/debate › Research › peer-review
Harvard
Villasante-Tezanos, AG, Rohde, C
, Nielsen, J & de Leon, J 2020, '
Pneumonia risk: approximately one-third is due to clozapine and two-thirds is due to treatment-resistant schizophrenia',
Acta Psychiatrica Scandinavica, vol. 142, no. 1, pp. 66-67.
https://doi.org/10.1111/acps.13184APA
Villasante-Tezanos, A. G., Rohde, C.
, Nielsen, J., & de Leon, J. (2020).
Pneumonia risk: approximately one-third is due to clozapine and two-thirds is due to treatment-resistant schizophrenia.
Acta Psychiatrica Scandinavica,
142(1), 66-67.
https://doi.org/10.1111/acps.13184Vancouver
Villasante-Tezanos AG, Rohde C
, Nielsen J, de Leon J.
Pneumonia risk: approximately one-third is due to clozapine and two-thirds is due to treatment-resistant schizophrenia.
Acta Psychiatrica Scandinavica. 2020;142(1):66-67.
https://doi.org/10.1111/acps.13184Author
Villasante-Tezanos, A. G. ; Rohde, C. ; Nielsen, J. ; de Leon, J. / Pneumonia risk : approximately one-third is due to clozapine and two-thirds is due to treatment-resistant schizophrenia. In: Acta Psychiatrica Scandinavica. 2020 ; Vol. 142, No. 1. pp. 66-67.
Bibtex
@article{a729ab8f3c0247b2aa3fa0e1335dfcfd,
title = "Pneumonia risk: approximately one-third is due to clozapine and two-thirds is due to treatment-resistant schizophrenia",
keywords = "clozapine/adverse effects, clozapine/toxicity, infection, pneumonia, respiratory aspiration",
author = "Villasante-Tezanos, {A. G.} and C. Rohde and J. Nielsen and {de Leon}, J.",
note = "Funding Information: These analyses received no specific grant from any funding agency, commercial or not-for-profit sectors. The authors acknowledge Lorraine Maw, M.A., at the Mental Health Research Center at Eastern State Hospital, Lexington, KY, who helped in editing this article.",
year = "2020",
doi = "10.1111/acps.13184",
language = "English",
volume = "142",
pages = "66--67",
journal = "Acta Psychiatrica Scandinavica",
issn = "0001-690X",
publisher = "Wiley",
number = "1",
}
RIS
TY - JOUR
T1 - Pneumonia risk
T2 - approximately one-third is due to clozapine and two-thirds is due to treatment-resistant schizophrenia
AU - Villasante-Tezanos, A. G.
AU - Rohde, C.
AU - Nielsen, J.
AU - de Leon, J.
N1 - Funding Information:
These analyses received no specific grant from any funding agency, commercial or not-for-profit sectors. The authors acknowledge Lorraine Maw, M.A., at the Mental Health Research Center at Eastern State Hospital, Lexington, KY, who helped in editing this article.
PY - 2020
Y1 - 2020
KW - clozapine/adverse effects
KW - clozapine/toxicity
KW - infection
KW - pneumonia
KW - respiratory aspiration
U2 - 10.1111/acps.13184
DO - 10.1111/acps.13184
M3 - Comment/debate
C2 - 32415875
AN - SCOPUS:85088152705
VL - 142
SP - 66
EP - 67
JO - Acta Psychiatrica Scandinavica
JF - Acta Psychiatrica Scandinavica
SN - 0001-690X
IS - 1
ER -
